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Chromatin and sequence features that define the fine
and gross structure of genomic methylation patterns
John R. Edwards,1,8 Anne H. O’Donnell,2,8 Robert A. Rollins,3 Heather E. Peckham,4
Clarence Lee,4 Maria H. Milekic,5 Benjamin Chanrion,6 Yutao Fu,4 Tao Su,7
Hanina Hibshoosh,7 Jay A. Gingrich,5 Fatemeh Haghighi,6 Robert Nutter,4
and Timothy H. Bestor2,9
1

Center for Pharmacogenomics, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA;
Department of Genetics and Development, College of Physicians and Surgeons of Columbia University, New York, New York 10032,
USA; 3Center for Integrative Biology and BioTherapeutics, Pfizer BioTherapeutics Research and Development, Pearl River, New York
10965, USA; 4Life Technologies, Beverly, Massachusetts, 01915 and Foster City, California 94404, USA; 5Department of Psychology
and the Sackler Institute of Developmental Neuroscience, Columbia University and the New York State Psychiatric Institute, New York,
New York 10032, USA; 6Division of Molecular Imaging and Neuropathology and the Department of Psychiatry, Columbia University
and the New York State Psychiatric Institute, New York, New York 10032, USA; 7Department of Pathology, College of Physicians and
Surgeons of Columbia University, New York, New York 10032, USA
2

Abnormalities of genomic methylation patterns are lethal or cause disease, but the cues that normally designate CpG
dinucleotides for methylation are poorly understood. We have developed a new method of methylation profiling that has
single-CpG resolution and can address the methylation status of repeated sequences. We have used this method to determine the methylation status of >275 million CpG sites in human and mouse DNA from breast and brain tissues.
Methylation density at most sequences was found to increase linearly with CpG density and to fall sharply at very high
CpG densities, but transposons remained densely methylated even at higher CpG densities. The presence of histone
H2A.Z and histone H3 di- or trimethylated at lysine 4 correlated strongly with unmethylated DNA and occurred primarily at promoter regions. We conclude that methylation is the default state of most CpG dinucleotides in the mammalian genome and that a combination of local dinucleotide frequencies, the interaction of repeated sequences, and the
presence or absence of histone variants or modifications shields a population of CpG sites (most of which are in and
around promoters) from DNA methyltransferases that lack intrinsic sequence specificity.
[Supplemental material is available online at http://www.genome.org. The methylation data from this study have been
submitted to the NCBI Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo) under accession no. GSE21242.]
The human genome contains ;28 million CpG sites, about 60% of
which are methylated at the 5 position of the cytosine. Methylation of relatively CpG-rich promoters causes strong transcriptional
repression (Stein et al. 1982; Lorincz et al. 2002), and many experiments have demonstrated faithful inheritance of methylation
patterns over many cell divisions in mammalian somatic cells
(Wigler et al. 1981; Lorincz et al. 2002). This heritability means
that genomic methylation patterns could have many biological
functions, and many such functions have been proposed over the
past 50 yr. However, much controversy as to the biological roles of
genomic methylation patterns remains because of the lack of information about the genome-wide structure of methylation patterns. A further concern is the common use of cultured cells in
methylation profiling studies; genomic methylation patterns are
unstable in cultured cells, and promoters of tissue-specific genes
that are methylated in cultured cells are usually unmethylated in
both expressing and nonexpressing tissues (Jones et al. 1990).
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Half of all CpG sites are contained in repetitive DNA (Rollins
et al. 2006), but existing methods of methylation profiling are
largely or completely unable to evaluate methylation at dispersed
and tandem-repeated sequences. This is a severe shortcoming, as
the methylation of such sequences can have strong effects on
phenotype. Human ICF syndrome is caused by mutations in the
DNMT3B gene that prevent methylation of specific classes of
tandem-repeated sequences (Xu et al. 1999), while Fragile X syndrome is caused by de novo methylation provoked by expansion
of a CGG repeat tract at the FMR1 locus (Sutcliffe et al. 1992).
Transposon insertion alleles of mouse genes such as nonagouti
(also known as agouti) (a) and Axin1 show highly variable penetrance and expressivity that are dependent on the methylation
state of the transposon (Michaud et al. 1994; Rakyan et al. 2001).
We have developed a new method called Methyl-MAPS
(methylation mapping analysis by paired-end sequencing) that
can provide coverage of up to 82.4% of the CpG sites in the genome (Supplemental Fig. S1). This method probes methylation
status at single-copy and repetitive elements, each of which represents ;50% of the CpGs in the genome (Rollins et al. 2006). The
method combines enzymatic fractionation of the genome into
methylated and unmethylated compartments with deep sequencing to provide a comprehensive profile of genomic methylation
patterns. A comparison of Methyl-MAPS to other techniques for
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methylation profiling shows that Methyl-MAPS provides high coverage of single-copy and repeated sequences at relatively low cost
(Supplemental Table S3). We have applied Methyl-MAPS to determine the structure of genomic methylation patterns at both fine and
gross levels and have found sequence contexts and specific chromatin marks that are tightly associated with methylation status.

Results and Discussion
The methylated compartment of the genome was isolated by digestion with five methylation-sensitive restriction endonucleases
(RE), while the unmethylated compartment was isolated by limit
digest with the methylation-dependent McrBC complex (Supplemental Fig. S1). Paired-end libraries were prepared, and 25 bases
from both ends of each DNA molecule were determined by sequencing-by-ligation on Applied Biosystems SOLiD System DNA
sequencers (see Methods). CpG methylation was then determined
by analyzing which CpGs were resistant or sensitive to cleavage by
McrBC or RE (Supplemental Fig. S1). The use of paired-end sequencing allows direct determination of the methylation status
of interspersed repeated sequences, as in the majority of cases one
or both end tags are anchored in unique sequence. A total of
15,154,064 unmethylated sequences and 21,393,168 methylated
sequences from somatic DNA were mapped to unique locations in
the genome (hg18, mm9), and mean coverage at sites cleavable by
McrBC and RE was 7.1X (Supplemental Table S1). The methylation
status of 152,693,954 CpG dinucleotides was determined in human
breast DNA, 75,676,854 in human brain DNA, and 52,896,012 in
mouse brain DNA, for a total of 281,266,820 CpG sites.
We validated the Methyl-MAPS results by comparison to bisulfite methylation analysis on the Illumina Infinium HumanMethylation 27 beadchip and found that Pearson’s correlation
coefficient for methylation data obtained via the two unrelated
methods was 0.84 for breast 1 and 0.87 for breast 2. This is substantially greater than correlations obtained by pairwise comparison of other DNA methylation profiling methods (Irizarry et al.
2008). To further confirm that accurate methylation data were
obtained by Methyl-MAPS, sequences known to be methylated on
the female X chromosome and at imprinted loci were examined.
Promoter-associated islands on female chr X were much more
methylated than were promoter-associated islands on the male
chr X, whereas islands on male and female autosomes were less
methylated (Supplemental Fig. S2A). An analysis of all known
differentially methylated regions (DMRs) at imprinted loci showed
DMRs to be methylated at intermediate densities, as expected
for sequences subject to allele-specific methylation (Supplemental
Table S2; Supplemental Fig. S2B).
The methylation status of the BIK (BCL2 interactor and killer)
gene in DNA from normal human breast tissue is shown in Figure
1A. The pattern of methylation of this gene is typical in that the
CpG-rich promoter and flanking sequences are unmethylated,
whereas the bulk of the gene is methylated. Methyl-MAPS can be
used to directly measure the methylation of repetitive sequences,
as shown in Figure 1B. The SVA retrotransposon in this repeat-rich
genomic region is densely covered by methylated fragments,
which is typical of both dispersed and repeated sequences in the
mammalian genome.
Analysis of the observed methylation patterns revealed a significant relationship between CpG density and methylation density (Fig. 2). Previously, it has been established that regions of high
CpG density in promoters are largely unmethylated (Weber et al.
2008); however, only promoter regions were studied, and the re-

lationship between CpG density and methylation at nonpromoter
sequences and in repeats has not been elucidated. In single-copy
DNA, the fraction of methylated CpGs was found to increase with
CpG density up to a density of 0.025 (one out of 40 nucleotides [nt]
is a C in a CpG dinucleotide), where 70% of the CpG sequences
were methylated (Fig. 2A,C). Over 90% of the CpGs found in single-copy sequence are found at these lower CpG densities with
higher levels of methylation. At higher CpG densities, methylation density fell off sharply, and methylation of unique sequences
was lowest at very CpG-rich promoters. A similar pattern was seen
for repeated sequences (Fig. 2B); for these sequences, methylation
increased up to a CpG density of 0.07 (one out of ;15 nt is a C in
a CpG dinucleotide), where 80% of CpGs were methylated; thus,
these repeated sequences, which are largely composed of transposable elements, continue to be methylated at very high CpG
densities. Methylation in repeated sequences was low only in CpG
containing simple sequence repeats of 2–6 nt. These methylation
patterns were very similar in human breast and brain DNA (Supplemental Fig. S3) and in mouse brain DNA (Supplemental Fig. S4),
and indicate that these trends are fundamental features of the
methylation program in mammalian somatic tissues. The unmethylated, CpG-dense compartment was found to be populated by two
very different sequence types: single-copy promoter-associated CpG
islands (Fig. 2C) and simple sequence repeats of 2–6 nt (Fig. 2B). The
overall trend of increasing CpG methylation with increasing CpG
density at low- to mid-CpG densities with very low levels of CpG
methylation at high CpG densities was observed across all sequence classes (Fig. 3D; Supplemental Fig. S7).
Figure 4B shows DNA methylation and CpG distributions
averaged across 16,181 RefSeq genes. As expected from the presence of CpG islands at most promoters, the density of CpG dinucleotides was very high in first exons, with the high CpG density
extending well 59 and 39 of the first exon. These CpGs were
undermethylated, with the density of unmethylated CpGs reaching a maximum at the transcription start site (TSS). CpG-poor
promoter regions are partially methylated (Supplemental Figs. S5,
S7), but the methylation density is likely to be too low to enforce
transcriptional silencing (Kass et al. 1997; Weber et al. 2008). Figure 4C shows that methylation status across multiple sequence
compartments is very similar between unrelated individuals.
CpG islands near TSSs are unmethylated (Supplemental Fig.
S6); however, only ;40% of computationally annotated CpG islands are located near TSSs. Our analysis of length and methylation
density showed that non-TSS islands were much more likely to be
methylated and were much shorter than were TSS islands (Supplemental Fig. S6). Both tendencies were less pronounced for intergenic CpG islands, some of which may be associated with novel
TSSs for genes that encode unknown transcripts.
Within coding regions of genes, we also found unanticipated
patterns of methylation at the borders of exons. We observed an
increase in the density of CpG sites at the 59 and 39 ends of internal
exons (Majewski and Ott 2002), and these CpG sites were relatively
highly methylated. As can be seen in Figure 4C, the sequence compartments in which the fraction of unmethylated CpG sites is lowest
are SINE (largely Alu) transposons and internal exons of cellular
genes. The presence of densely methylated coding exons was surprising, as 5-methylcytosine (m5C) is a premutagenic modified
base that leads to C ! T mutations at a rate 18-fold higher than the
average of all other point mutations (Kondrashov 2003). The high
methylation and CpG densities at exon ends could increase the efficiency of splice-site selection via recruitment of MECP2, which has
been reported to bind to m5C and has been reported to be required
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Figure 1. High-resolution genome-wide methylation profiling and genome-wide DNA methylation trends. (A) Browser view of Methyl-MAPS data from
the genomic region spanning the BIK gene. Individual mapped sequence reads are shown in the top raw data tracks. Red sequences were resistant to
methylation-sensitive restriction endonucleases (RE) and are therefore methylated. Blue sequences were resistant to the methylation-dependent McrBC
complex and are unmethylated. Tick marks in both tracks along the top of the figure and within each sequence indicate locations of individual RE and
McrBC recognition sequences. Methylation data is also presented in a concise view, where each CpG is assigned a methylation score from the ratio of
methylated to total (unmethylated and methylated) sequences covering each CpG site. The bulk of the BIK gene is methylated, while the CpG-rich
promoter is unmethylated. (B) Methylation of the SVA retrotransposon in a repeat-rich region of chr 19. While the CpG density is comparable to that of the
CpG island of the BIK gene shown in A, the SVA retrotransposon is densely methylated.

for accurate pre-mRNA splicing (Young et al. 2005); however, the
increase in CpG density and methylation density is also apparent
just 59 of the stop codon, which is not associated with a splice site.
There is considerable interest in the relationship between
DNA methylation and histone modifications. Large databases that
describe the distribution of histone modifications and chromatin
proteins over the genome have been derived by chromatin immunoprecipitation (Barski et al. 2007; Mikkelsen et al. 2007) or
DNase I cleavage (Boyle et al. 2008), followed by deep sequencing.
We used these data to test for correlations of histone variants and
bound chromatin proteins with patterns of DNA methylation.
H3K36 methylation, H3K27 methylation, H3K79 methylation,
and H3K9 di-and trimethylation showed no strong correlation
with DNA methylation (Fig. 5A,B). In contrast, di- and trimethylation of lysine 4 of histone H3 (H3K4) showed a strong negative
correlation with DNA methylation. While previously it was shown
that H3K4Me2 was associated with unmethylated promoters
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(Weber et al. 2008), it is interesting that little correlation was found
with H3K4Me1, and the strength of the correlation increased with
the level of modification at H3K4. This is consistent with the
finding that de novo methylation is targeted to DNA sequences
associated with histones that are unmethylated at H3K4 via a domain in the methylation regulator DNMT3L that specifically recognizes unmethylated H3K4 (Ooi et al. 2007).
The binding of the H2A.Z histone variant correlates inversely
with DNA methylation (Fig. 5), demonstrating that these two
marks may be mutually exclusive in mammals, as was found recently in plants (Zilberman et al. 2008). Binding of CTCF also
correlated globally with unmethylated DNA, in agreement with
previous reports that CTCF binds to unmethylated DMRs at specific loci (Bell and Felsenfeld 2000; Hark et al. 2000). DNA methylation patterns have been shown to be subject to somatic inheritance in mammals, whereas there is little evidence for the
mitotic inheritance of histone marks and histone variants. DNA
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Comparison of our data to that from H1 ES cells (Lister et al.
2009) show that at the time of establishment, DNA methylation
patterns at lower CpG densities begin as highly methylated (Supplemental Fig. S9). Over time, in differentiated cells some methylation is lost in these CpG-poor regions. The data in Figures 2 and
4 suggest that the domains around CpG-dense promoters may be
inherently refractory to DNA methylation. To test this hypothesis
we examined the methylation state of Alu elements that fall into
promoter domains near first exons. Alu elements are normally
highly methylated (Fig. 3D), but Alu elements located within
;1000 bp of unmethylated first exons tend to be unmethylated
(Fig. 3A,B). This supports the hypothesis that single-copy CpG-rich
regions are shielded from the DNA methylation machinery. Interestingly, Alu elements are also depleted from these unmethylated domains (Fig. 3C), which suggests that Alu elements that
insert into these unmethylated regions reduce host fitness and are
lost from the population by selection.
DNA methylation has long been believed to regulate gene
expression via programmed removal of DNA methylation from
promoters by passive or active methylation to allow lineagespecific gene expression. Arguments against this model have been
raised (Walsh and Bestor 1999), and it has recently been reported
that the gain of DNA methylation at promoters in cells differentiating in vitro is much more prevalent than is a loss of promoter
methylation (Mohn et al. 2008). It has recently been shown that

Figure 2. Relationship of CpG density and methylation for repeated
and unique sequences. (A) CpG methylation is plotted as a function of
CpG density for four distinct genomic compartments (single copy, retrotransposons, simple repeats, and other repeats). Approximately 50% of
the CpGs in the genome are contained in both repeats (B) and unique
sequences (C ). Each curve is divided into four CpG density regions; the
CpG composition of each is shown in the bar charts on the right. The large
majority of CpGs are contained in region 1 in both plots (A, 96%; B,
81.9%). (B) The majority of low-CpG density CpGs are contained in SINE
and LINE elements, while the highly unmethylated high-density CpGs are
primarily found in simple repeats. (C ) The majority of low-CpG density
CpGs are contained in intergenic and intronic unique sequences, while the
highly unmethylated high-density CpGs are primarily found in promoterassociated regions.

methylation in mammals is dominant over histone methylation,
as shown by the faithful inheritance of DNA methylation patterns
on DNA introduced into cells (Wigler et al. 1981; Lorincz et al.
2002). As shown in Supplemental Figure 8, analysis of CpG loss
rates across primates indicates that the genomic methylation patterns observed in somatic cells are similar to those of male germ cells.

Figure 3. Relationship between CpG methylation at Alu retrotransposons
and proximity to methylated and unmethylated promoters. Alu methylation is plotted as a function of distance from the TSS (A) and to the 39
splice site of the first exon (B) of methylated (red) and unmethylated (blue)
first exons. When near unmethylated first exons, Alu elements are also
unmethylated. Alu methylation correlates with first-exon methylation
when Alus are within ;1 kb of the TSS or 39 edge of the first exon. (C )
Negative selection of Alu elements near unmethylated promoters. The
ratio of the fraction of methylated promoters with Alus near the first exon
to the fraction of unmethylated promoters with Alus near the first exon is
plotted as a function of the distance to the TSS. This suggests that
unmethylated Alus near promoters are deleterious and are lost from the
population by selection. (D) The methylation status of the three major
classes of Alu retrotransposons. Note that AluY (the only active Alu in the
human genome) remains heavily methylated, even at very high CpG
densities.
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Figure 4. (A,B) CpG distributions and methylation patterns in human genes. m5CpG and CpG densities are shown in relation to enhancers (A), TSS,
exon splice sites, stop codons, and poly(A) sites (B). Note spikes in CpG and m5CpG densities at the 59 and 39 ends of exons and internal to the stop codon
in the last exon. (C) Comparison of methylation patterns in normal breast tissue from two individuals. Methylation status of each CpG with high coverage is
computed for each sample. The frequency of such points is then plotted as a function of the methylation score for each sample. Heat map indicates
frequency. Values in the left corner are unmethylated in both samples. Values in the right corner are methylated in both samples. Values along the
horizontal are equivalently methylated in each sample. Some sequence classes have a wide range of methylation states, such as intronic and intergenic
single-copy sequences and LINEs, LTRs, and DNA transposons. Other classes such as SINEs, exons, simple repeats, and promoters are polarized.

the patterns of histone modification and histone variants at promoters are only weakly related to the level of expression of genes,
while chromatin modifications at enhancers are strongly associated with cell-type-specific gene expression (Heintzman et al.
2009). We examined the CpG and methylation density of 27,065
enhancers identified by Heintzmann and colleagues and found
that enhancers are characterized by very low levels of CpG and
DNA methylation (Fig. 4A). This indicates that enhancer methylation is unlikely to be involved in cell-type-specific gene expression. The lack of cell-type-specific methylation at either enhancers
or promoters indicates that DNA methylation is likely to have a
negligible or very small role in development, and that the methylation changes seen at some low-CpG promoters are likely to be
a result of transcriptional activation rather than a cause.
Our genome-wide data reveals features of methylation patterns that were not apparent in previous experiments that covered
small fractions of the genome (Eckhardt et al. 2006; Meissner et al.
2008; Mohn et al. 2008; Weber et al. 2008) or have known biases
with respect to CpG density (Supplemental Table S3; Down et al.
2008). The likelihood of methylation of a CpG dinucleotide depends in part on the local sequence environment: High CpG
density increases the probability that a CpG will be methylated up
to a limit, after which very high CpG densities repel DNA methylation. This trend includes exonic CpGs, which tend to be
methylated. Other factors that have been implicated in shaping
genomic methylation patterns include the piRNA pathway, which
targets classes of transposons for de novo methylation specifically
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in male germ cells (Carmell et al. 2007) and the binding of transcription factors, such as SP1 to methylated target sites, which can
induce demethylation of local CpG sites in dividing mammalian
cells (Matsuo et al. 1998; Lin et al. 2000).
Data shown here indicate that methylation is the default state
of nucleosomal DNA and could explain how genomic methylation
patterns are established and maintained by DNA methyltransferases
whose sequence specificity is limited to the CpG dinucleotide. The
heritability of genomic methylation patterns clearly shows that
once established, DNA methylation is dominant over chromatin
modifications. Sequences such as imprinting control regions, CpG
islands of the inactive X chromosome, and some transposons
and retroviruses are methylated as a result of poorly understood
pathways that direct de novo methylation specifically to these
sequences. The data indicate that the bulk of the genome is methylated as the default state, and unmethylated regions are protected
from a promiscuous DNA methylating system by a combination of
very high CpG densities and histone modifications and variants
(di- and trimethylated H3K4 and H2A.Z) that repel DNA methyltransferase complexes.

Methods
Isolation of genomic DNA
Human breast DNA was prepared from post-surgical specimens of
normal breast tissue adjacent to breast cancer tissue. Human brain
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to as RE), respectively (New England BioLabs). Two rounds of McrBC
digestion were performed to ensure sufficient digestion (13 NEB
Buffer 2, 23 GTP, 13 BSA, 10 U of McrBC per microgram starting
DNA at 37°C for 4–6 h). Each round of digestion was followed by
phenol-choloroform extraction (phenol:chloroform:isoamyl alcohol [25:24:1] at pH 8) and ethanol precipitation (add 1 mg/mL
glycogen [0.01 vol], 3 M sodium acetate at pH 5.3 [0.1 vol], and
ethanol [2 vol]; incubate at 20°C for 15 min; centrifuge at
20,800g at 4°C for 15 min; wash with 600 mL of cold 70% ethanol,
and centrifuge at 20,800g at 4°C for 5 min; air dry and resuspended
in 13 TE [10 mM Tris, 1 mM EDTA at pH 8]). Phenol-choloroform
extraction and ethanol precipitation is further referred to as PCP.
Following McrBC digestion, excess GTP was removed by purification with a Sephadex G50 column (GE Healthcare). RE digestion
was conducted in three consecutive rounds. Digestion was conducted with 10 U of restriction enzyme per microgram of starting
DNA with HpaII and HpyCH4IV (13 NEB Buffer 1, 37°C, 4–6 h),
AciI and HhaI (13 NEB Buffer 3, 13 BSA, 37°C, 4–6 h), and BstUI
(13 NEB Buffer 2, 60°C, 2–3 h). Each round of digestion was followed by PCP.

Paired-end library preparation

Figure 5. Relationship between DNA methylation, histone modification, chromatin proteins, and nucleosome positioning. (A) m5CpG and
CpG densities, ChIP-seq scores, and DNase hypersensitivity scores are
plotted relative to promoter TSSs for 16,181 RefSeq genes. (B) CpG
methylation plotted as a function of histone modifications, chromatin
factors, and RNA polymerase II occupancy. Note the strong negative relationship between DNA methylation and density of H3K4me3 and H2A.Z
and the lack of a strong association between DNA methylation status and
most histone modifications.

DNA was collected from gray matter from the left dorsolateral
prefrontal cortex. Mouse brain (strain 129 SvEv, from Taconic)
DNA was collected from the left hemisphere with the cerebellar
tissue removed.
DNA was prepared from tissues by pulverizing tissue under
liquid nitrogen and digesting overnight at 55°C (10 mM NaCl, 10
mM Tris at pH 8, 25 mM EDTA at pH 8, 0.5% SDS, 100 ng/mL
proteinase K). DNA was purified by phenol-chloroform extraction
and RNase A treatment, followed by ethanol precipitation. DNA
was stored in 10 mM Tris, 1 mM EDTA (pH 8) at 20°C. High
molecular weight quality of DNA was confirmed by agarose gel
electrophoresis and the DNA was quantified on a Qubit fluorometer (Invitrogen).

Enzymatic fractionation by methylation state
Unmethylated and methylated compartments were obtained by
limit digestions of 10–15 mg of DNA with McrBC or five tetranucleotide methylation-sensitive restriction endonucleases (referred

Paired-end libraries were prepared from the methylated and unmethylated DNA compartments by following an adaptation of
Applied Biosystems’ SOLiD System Mate-paired Library Preparation Protocol. Adaptor sequences can be found in the manufacturer’s instructions. DNA fragment ends were repaired using T4
DNA polymerase and T4 polynucleotide kinase (13 NEB PNK
buffer, 0.1 mg/mL BSA, 0.4 mM ATP, 0.4 mM dNTPs, 50 U of enzyme) at 12°C for 15 min, then 25°C for an additional 15 min.
Unincorporated dNTPs were removed with a Sephadex G50 column followed by PCP. Endogenous EcoP15I sites were methylated
with EcoP15I (13 NEB Buffer 3, 13 BSA, 360 mM SAM, 10 U of
enzyme per measured microgram of DNA). Successful EcoP15I
methylation was confirmed by resistance to digestion by EcoP15I
of a control EcoP15I-methylated sample performed in parallel with
library samples. A 100 molar ratio excess of CAP adaptors (containing EcoP15I sites) was ligated onto the end-polished, EcoP15Imethylated DNA molecules (13 Invitrogen ligase buffer [53], 30 U
of Ambion T4 DNA ligase), followed by PCP.
Samples were run on a 1% TAE low-melt agarose gel at 45 V for
2.5 h. The gel was size fractionated at 800 bp to remove digested
DNA and unligated CAP adaptors. DNA fragments were collected
in several size fractions (McrBC: 0.8–2 kb, 2–5 kb, >5 kb; RE: 0.8–1.5
kb, 1.5–3 kb, 3–6 kb, >6 kb) and extracted using the GENECLEAN
Glassmilk Spin Column Kit (MP Biomedicals). DNA from each size
fractionation was circularized separately with a 3 molar excess of
biotinylated internal adaptor (T30B) at 16°C overnight (13
Ambion ligation buffer and 30 U of Ambion T4 DNA ligase) under
concentration conditions that promote 95% circularization efficiency of DNA molecules of each length range. The DNA concentration I was calculated
pﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃas I (ng/uL) = [ J/(95% intramolecular)]
 J and J = 63.4/ kb DNA, where J is the Jacobson-Stockmayer
factor, the effective local concentration of one end of the DNA
molecule in the vicinity of the other (Collins and Weissman 1984).
An additional 2.5 U of ligase was added 1 h after circularization
commenced, and again 1 h before the reaction was terminated.
Uncircularized DNA molecules were degraded with plasmid-safe
DNAse treatment (62.5 mM ATP, 0.0625 U/mL ATP-dependent
DNase) (Epicentre) and the enzyme was heat inactivated (70°C for
20 min). Following PCP, the four RE fractions were combined into
<2-kb and >2-kb fractions. Excess nucleotides were removed using a G50 Sephadex column. Circularized DNA was digested with
EcoP15I (10 U per 100 ng of circularized DNA) overnight at 37°C
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(13 NEB Buffer 3, 13 BSA, 2 mM ATP, 0.1 mM Sinefungin). Fresh
ATP, BSA, and Sinefungin were added the following morning 1 h
before termination of the reaction by heat inactivation. The
digested DNA was end repaired by 5 U of Klenow (New England
BioLabs) in the presence of 25 mM dNTPs at room temperature for
30 min, followed by heat inactivation at 65°C for 20 min. Sixty
molar excess P1ds and P2ds linkers containing primer sequences
for PCR were ligated onto the ends of the DNA molecules in
250 uM ATP and 20 U of T4 DNA ligase (Ambion).
M280 Strepavidin beads (Invitrogen) were prewashed with
once 13 BBW buffer (2% Tween 20, 2% Triton X-100, 10 mM
EDTA), 13 BSA, and 13 BW buffer (10 mM Tris-HCl, 1 M NaCl, 1
mM EDTA). DNA was bound through the biotin tag on the internal
adaptor to 15 mL of prewashed M280 strepavidin beads (Invitrogen) for 15 min at room temperature in a final concentration of
13 BW buffer. Bound beads were washed once with 13 BBW
buffer, twice with 1X BW buffer, and once with 13 NEB Buffer 2.
The beads were resuspended in 13 NEB Buffer 2 with 500 mM
dNTPs and 15 U of DNA polymerase I (New England BioLabs) and
incubated at 16°C for 30 min. A test PCR at 20 cycles was done to
confirm the presence of the expected 156-bp DNA product; cycles
were titrated up and down as needed to produce sufficient product.
A large-scale PCR was performed on the entire population of beads
(95°C for 5 min, 18–22 cycles of 95°C for 15 sec, 62°C for 15 sec,
70°C for 1 min, followed by a final extension at 70°C for 5 min and
storage at 4°C indefinitely). Each 50-mL reaction contained 1 uL of
bead template, 1 mL of 50 mM L-PCR-P1 primer, 1 mL of 50 mM
L-PCR-P2 primer, and 47 mL of Platinum PCR Supermix (Invitrogen). Reactions were combined and ethanol precipitated.
A 6% DNA retardation PAGE gel (Invitrogen) was prerun for 5
min at 115 V. Using Ficoll loading dye, the samples and a 25-bp
ladder (Invitrogen) were run on a 6% DNA retardation PAGE gel in
13 TBE at 115 V for 45 min. To visualize the bands, the gel was
stained in 1:6000 ethidium bromide (10 mg/mL) in 13 TBE for 5
min and destained twice in water. The 156-bp library band was
dissected from the gel and shredded. DNA was extracted from the
shredded gel in 200 mL of PAGE elution buffer (1:5 7.5 M ammonium acetate in 13 TE) at room temperature for 20 min and 250 mL
PAGE elution buffer at 37°C for 40 min. The gel and buffer were
separated on a 0.45 micron filter spin column. The DNA was ethanol precipitated. The resuspended DNA was purified with a
MinElute Reaction Cleanup Kit (Qiagen) and eluted in 20 mL of
10 mM Tris and an additional 20 mL of 10 mM Tris was added to
bring the final library volume to 40 mL. DNA quantity was assessed
on a Qubit fluorometer (Invitrogen) and quality and quantity on
a Bioanalyzer DNA 1000 LabChip (Agilent).

was reported if a single uniquely placed pair could be made from
the hits of each tag that met the constraints of order, orientation
and distance (0–15 kb). If no mate pair could be made, then matepair rescue was attempted in which each hit was used as an anchor
and the region where an appropriate mate should be found was
scanned while allowing a total of four mismatches in both tags. A
rescued mate pair was reported if a single uniquely placed pair
could be made.

Data filtering and CpG analysis
A custom Perl script was written to parse the output files from the
Applied Biosystems SOLiD System and filter sequences that did not
have at least one restriction site (McrBC or RE, respectively) at the
fragment ends. Since methylated (RE) and unmethylated (McrBC)
compartments are sampled independently, it is important to find
the correct ratio of RE:McrBC fragments that represents the ‘‘true’’
distribution that would be obtained from a random sampling of
the genome. This ratio can be determined numerically since, if you
fix the total number of McrBC + RE fragments, then using the ratio
that matches the underlying ‘‘true’’ distribution should yield the
maximum physical coverage. This ratio was estimated by finding
the ratio of McrBC and RE fragments that maximized coverage on
a subset of chromosomes (chromosomes 16–21). All McrBC and RE
fragments were then overlapped with an indexed list of CpGs in
hg18. The number of unmethylated observances at each CpG, nu,
was set equal to the number of RE fragments that terminated at
that CpG plus the number of McrBC fragments containing that
CpG in its interior (>50 bp from the end). The number of methylated observances, nm, at a particular CpG was calculated as the
sum of all RE fragments to which a particular CpG was interior. The
coverage of a CpG at position i is then given as C(i) = nm(i) + nu(i)
and the methylation score is calculated as m(i) = nm(i)/C(i).
CpG island, RepeatMasker, RefSeq gene data, and other genomic annotation information was downloaded from the UCSC
Genome Browser website (http://genome.ucsc.edu). The average
methylation score of a genomic element e is calculated as
^
mðeÞ
=

1
+mðiÞ
NðeÞ

where N(e) is the total number of CpGs in that element and where
C(i) $ 7 and each CpG at position i are both McrBC and RE sites. All
annotation and methylation data, indexed by the CpG site was
then stored in a MySQL database that could be used directly for
calculations.

Model gene analysis
DNA sequencing
Individual library fragments were amplified on 1-mm beads using
emulsion-PCR according to the Applied Biosystems SOLiD System
emulsion PCR standard protocol. Samples were subjected to pairedend sequencing on an Applied Biosystems SOLiD System DNA
sequencer. Twenty-five base-pair sequences were obtained for both
R2 and F2 tags on each bead. Mouse and Human brain samples
were sequenced using the same protocol at Agencourt Biosciences.

A total of 16,841 RefSeq genes with annotated coding sequence
start and end points and greater than two exons were considered
for this analysis. Analysis of CpG density (rCpG) was performed as
in Majewski and Ott (2002). meCpG density (rmeCpG) at position x
relative to the end of an exon was estimated as
rmeCpG ðxÞ » r m ðxÞrCpG ðxÞ;
where
r m ðxÞ =

Tag mapping
Initial tag mappings were performed with the Applied Biosystems
SOLiD System software analysis package. Paired tags were each
individually mapped in color space, allowing up to two mismatches in each 25-bp tag to the human hg18 sequence obtained
from the UCSC Genome Browser (http://genome.ucsc.edu). Up to
10 hits per chromosome were recorded for each tag. A mate pair
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1
+ mði; xÞ
NðxÞ i2fHg

and H = {all CpG that are McrBC and RE sites and C(i) $ 7}.

CpG island analysis
Each island was annotated according to its genomic location
(promoter, exon, intron, intergenic) in hierarchical fashion. Promoter
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islands were defined as islands that occur within 1 kb of a gene
TSS. Exon and intron islands must overlap exons and introns, respectively. All islands not labeled as promoter, exon, or intron were
labeled as intergenic. CpG island lengths for islands of each class
could then be calculated directly. Average methylation scores,
^
mðeÞ,
were then calculated for island CpGs with coverage C(i) $ 7
and which were both McrBC and RE sites that had a particular
annotation and a particular CpG density. Scores were similarly
computed for promoter-associated islands on chr X and autosomes.

DMR analysis
Methylation scores were calculated for all CpGs in each wellcurated differentially methylated region (see Supplemental Table 2
online) that are McrBC and RE sites with coverage C(i) $ 7.

Histone analysis
Chromatin immunoprecipitation with massively parallel sequencing (ChIP-seq) data was obtained directly from http://
dir.nhlbi.nih.gov/papers/lmi/epigenomes/hgtcell.aspx. The number of fragments covering each CpG (assuming a 200-bp length,
which is equal to the average fragment length) for each mark was
then computed and normalized to the total number of sequences
obtained. Methylation scores could then be computed as a function of the normalized ChIP-seq score.

^
Browser website. Average methylation scores, mðeÞ,
were then
calculated for CpGs that had a particular annotation and a particular CpG density as for other elements. A total of 16,181 wellannotated RefSeq genes were divided into CpG-rich (HCG) and
CpG-poor (LCG) promoter classes using an observed/expected
(O/E, calculated as above) cutoff of 0.35.
^
The average methylation score, mðeÞ,
of Alu-annotated CpGs
was computed as a function of their distance to annotated RefSeq
genes with either methylated or unmethylated first exons. Exon
methylation was determined if over 70% of the sites that were both
McrBC and RE sites had coverage C(i) $ 5. Exons were deemed
methylated if the average methylation score of these CpGs was
greater than 0.7 and unmethylated if this score was less than 0.3.
Alu average methylation scores are smoothed with a 200-bp sliding
window.
To compute the fraction of Alus near methylated and unmethylated promoters, the Alu density as a distance to the TSS was
calculated for each gene. Promoter methylation was determined if
over 70% of the sites that were both McrBC and RE sites had
coverage C(i) $ 5. Promoters were defined as the region 1 kb upstream of the TSS. Promoters were deemed methylated if the average methylation score of these CpGs was greater than 0.7 and
unmethylated if this score was less than 0.3, and the ratio of
fraction of methylated to the fraction of unmethylated promoters
with nearby Alus was computed. This ratio was then smoothed
with a 100-bp sliding window.

Promoter analysis
Promoters were defined as the region 1-kb centered on the transcription start site (TSS) of RefSeq genes whose cdsStart and cdsStop
were annotated as complete. Promoter distribution was calculated
as a function of CpG observed/expected (O/E) calculated across the
entire 1-kb region where
O=E =

ntotal nCpG
n 2 :
gc
2

Promoter distribution was also calculated as a function of CpG
density of the 1-kb region centered on the TSS. The average meth^
ylation score, mðeÞ,
was then calculated for all CpGs in the 1-kb
region centered on the TSS with the given CpG O/E or CpG density.

Estimate of the theoretical coverage of Methyl-MAPS
As an example to calculate the theoretical maximum coverage,
assume the genome is 60% methylated. There are 28,163,863
CpGs in the human genome (hg18), implying that 16,898,318 are
methylated and 11,265,545 are unmethylated. Of the methylated
CpGs, ;37% (6,252,378) will be RE sites; and of unmethylated
CpGs, ;76% (8,561,814) will be McrBC sites. Thus, in theory,
14,814,192 CpGs could be probed using this technique. In reality
there is not a single copy of the genome present, and methylation
patterns can be heterogeneous (see Fig. 1A); therefore, the number
of CpG sites that can be probed will be higher. These numbers are
highly dependent on the exact fraction of the genome that is
methylated.

CpG annotation
Nonrepeat-associated CpGs were annotated as promoter, exon,
intron, or intergenic. CpGs were assigned a single category given
preference in the order of the above list. Exon and intron locations
were based on complete RefSeq entries. Promoters regions were
defined as 1-kb upstream of or downstream from the TSS. For
humans, a list of TSSs was obtained using the SwitchGear TSS track
(http://www.switchgeargenomics.com) on the UCSC Genome
Browser. For mouse, a list of TSSs was obtained from the UCSC
knownGene track. Repeat-associated CpGs were annotated from
the RepeatMasker entries (http://www.repeatmasker.org) from the
appropriate tracks on the UCSC Genome Browser. Average meth^
ylation scores, mðeÞ,
were then calculated for CpGs that had a
particular annotation and a particular CpG density.
CpGs associated with exons of complete RefSeq entries were
classified as belonging to first, internal, and last exons. Average
^
methylation scores, mðeÞ,
were then calculated for CpGs that had
a particular annotation and a particular CpG density.

Alu analysis
CpGs were annotated as belonging to AluS, AluY, or AluJ from the
RepeatMasker annotations downloaded from UCSC’s Genome

Acknowledgments
We thank J.J. Mann, A. Dwork, and P. Graham for providing the
human brain tissue; J. Manning for providing informatics support
for the tag mappings; and L. Zhang and B. Coleman for aid with the
sequencing. We thank Reiner Schultz for the annotated list of
DMRs. This work was funded by NHGRI (T.H.B.), NCI (T.H.B. and
J.R.E.), NIMH (F.H.), NIDA (J.A.G.), DOD and NIMH (A.H.O.), and
the Simons Foundation (J.A.G.).

References
Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev
I, Zhao K. 2007. High-resolution profiling of histone methylations in the
human genome. Cell 129: 823–830.
Bell AC, Felsenfeld G. 2000. Methylation of a CTCF-dependent boundary
controls imprinted expression of the Igf2 gene. Nature 405: 482–488.
Boyle AP, Davis S, Shulha HP, Meltzer P, Margulies EH, Weng Z, Furey TS,
Crawford GE. 2008. High-resolution mapping and characterization of
open chromatin across the genome. Cell 132: 311–317.
Carmell MA, Girard A, van de Kant HJ, Bourc’his D, Bestor TH, de Rooij DG,
Hannon GJ. 2007. MIWI2 is essential for spermatogenesis and
repression of transposons in the mouse male germline. Dev Cell 12: 503–
514.

Genome Research
www.genome.org

979

Downloaded from genome.cshlp.org on December 18, 2013 - Published by Cold Spring Harbor Laboratory Press

Edwards et al.
Collins FS, Weissman SM. 1984. Directional cloning of DNA fragments at
a large distance from an initial probe: A circularization method. Proc Natl
Acad Sci 81: 6812–6816.
Down TA, Rakyan VK, Turner DJ, Flicek P, Li H, Kulesha E, Gräf S, Johnson N,
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Schübler D. 2008. Lineage-specific polycomb targets and de novo DNA
methylation define restriction and potential of neuronal progenitors.
Mol Cell 30: 755–766.
Ooi SK, Qiu C, Bernstein E, Li K, Jia D, Yang Z, Erdjument-Bromage H,
Tempst P, Lin SP, Allis CD, et al. 2007. DNMT3L connects unmethylated
lysine 4 of histone H3 to de novo methylation of DNA. Nature 448: 714–
718.
Rakyan VK, Preis J, Morgan HD, Whitelaw E. 2001. The marks, mechanisms
and memory of epigenetic states in mammals. Biochem J 15: 1–10.
Rollins RA, Haghighi F, Edwards JR, Das R, Zhang , Ju J, Bestor TH. 2006.
Large-scale structure of genomic methylation patterns. Genome Res 16:
157–163.
Stein R, Razin A, Cedar H. 1982. In vitro methylation of the hamster adenine
phosphoribosyltransferase gene inhibits its expression in mouse L cells.
Proc Natl Acad Sci 79: 61–67.
Sutcliffe JS, Nelson DL, Zhang F, Pieretti M, Caskey CT, Saxe D, Warren
ST.1992. DNA methylation represses FMR-1 transcription in fragile X
syndrome. Hum Mol Genet 1: 1397–1400.
Walsh CP, Bestor TH. 1999. Cytosine methylation and mammalian
development. Genes Dev 13: 26–34.
Weber M, Hellmann I, Stadler MB, Ramos L, Pääbo S, Rebhan M, Schübeler
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